The Biomarker World Congress 2007
May 15-17 Philadelphia, PA

The signature event in Cambridge Healthtech Institutes Biomarker Series, The Biomarker World Congress 2007 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providersmaking the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.

Event features:

500+ delegates, 50+ speakers, 50+ posters, 30+ exhibits, and more
Five concurrent tracks of break-out sessions, covering biomarkers in drug discovery, clinical development, molecular diagnostics, assay development, and pharmaceutical decision making
New track on biomarker assay development
Executive ThinkTanks offering qualified attendees an opportunity for facilitated brainstorming of key strategic issues
More pre-conference workshops and tutorials
Expanded new technology showcases and trade show

Coverage Includes:

Biomarkers in translational medicine
Pharmacogenomics
Pharmacodiagnostics
Biomarker assay development and validation
Biomarkers for molecular diagnostics
Clinical validation of biomarkers
Biomarkers for clinical pharmacology
Biomarkers for patient selection
Biomarkers to monitor response to therapy
Biomarker discovery strategies
Biomarker data analysis
Genomic, proteomic and matabolomic biomarkers
Biomarkers for toxicity and MOA assessment
Disease-specific biomarkers: cancer, CNS and inflammatory diseases
Biomarkers for go/no-go decisions
Impact of biomarkers on medicine
Regulatory issues

Link: http://www.biomarkerworldcongress.com/